The United Kingdom's Contribution to the European Development Fund (EDF) for Aid under the Cotonou Agreement. This project was approved before the referendum on the UK’s membership of the EU. Work is now under way to understand the implications of leaving the EU for the UK’s development work
UK contribution to the 18th Replenishment of the World Bank International Development Association (IDA 18)
UK contributions to compensate IDA the costs of foregone debt service payments under the Multilateral Debt Relief Initiative (MDRI)
Multilateral World Bank-administered funds to help developing countries pilot low-carbon, climate-resilient pathways. This is funded by both the Department for International Development and the Department of Enegry and Climate Change (DECC). This refers only to the DECC spend.;
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
To tackle the immediate impact of the three most deadly infectious diseases – HIV/AIDS, tuberculosis and malaria – and put the international community on the right track to end the three diseases as epidemics by 2030.
Gavi supports vaccine delivery in 68 of the world's poorest countries reaching 60% of the world's birth cohort. Gavi immunises children against vaccine preventable diseases including measles, rubella, meningitis, cervical cancer, pneumonia and diarrhoea. Gavi has played a significant role in the recent halving of global child mortality. Over the 2016 to 2020, Gavi will fully deliver the UK target to immunise 76 million children and save 1.4 million lives. Gavi targets reaching those in hard to reach areas, the poorest, and the most marginalised. Gavi has a major global market shaping role for vaccines, negotiating lower prices for low-income countries, and incentivising new vaccines such as for Ebola and Malaria.
To support development and poverty reduction through environmental protection, and help developing countries respond to climate change
To scale up access to treatment for HIV/Aids, Malaria and Tuberculosis for poor people by funding programmes that (often through bulk international procurement) lower the price of quality drugs and diagnostics and accelerating the pace at which they are made available.
To provide core funding support to seven UN agencies – Central Emergency Response Fund (CERF); Office for the Coordination of Humanitarian Affairs (OCHA); United Nations High Commissioner for Refugees (UNHCR); UN Children’s Emergency Fund (UNICEF); World Food Programme (WFP); World Health Organisation (WHO); and the International Organisation of Migration (IOM) to support a strengthened humanitarian response and a more efficient, effective and transparent system. These UK funds will enable these UN agencies to respond rapidly to urgent humanitarian needs and shore-up operations in neglected or protracted Crises.